Mar 31, 2010 | Laboratory News, Laboratory Pathology
Pathology labs would generally benefit if Judge Sweet’s ruling is upheld on appeal It was positive news for many clinical pathology laboratories when a judge ruled against Myriad Genetics and the University of Utah Research Foundation in the federal suit attacking its patents for the BRCA1 and BRCA2 genes. The suit was brought by a group of patients, medical organizations and the American Civil Liberties Union (ACLU). In Association for Molecular Pathology, et al v. U.S. Patent and Trademark...
Feb 12, 2010 | Laboratory News, Laboratory Pathology, Uncategorized
Court case will directly affect future development of new pathology and molecular tests In New York’s Southern District Court, a trial is underway that tests the legality of patenting genes. In Association for Molecular Pathology, et al v. U.S. Patent and Trademark Office 09-civ-4515, pathologist groups, patient advocacy groups, and the American Civil Liberties Union (ACLU) are challenging patents for the BRCA I and BRCA II genes which are held by the University of Utah and licensed...
